Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Heico
HEI
(FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -55.20%15.1B | -57.69%8.86B | --5.47B | -6.21%33.7B | 41.77%20.95B | 113.00%35.93B | 67.83%14.78B | 14.98%16.87B | 22.97%8.8B | -23.78%14.67B |
Operating income | -55.20%15.1B | -57.69%8.86B | -6.21%33.7B | 41.77%20.95B | 113.00%35.93B | 67.83%14.78B | 14.98%16.87B | 22.97%8.8B | -23.78%14.67B | |
Cost of sales | 20.00%-17.61B | 22.62%-9.42B | ---- | -19.38%-22.01B | -58.19%-12.17B | -63.22%-18.43B | -48.51%-7.69B | -3.44%-11.29B | 3.28%-5.18B | 25.07%-10.92B |
Operating expenses | 20.00%-17.61B | 22.62%-9.42B | -19.38%-22.01B | -58.19%-12.17B | -63.22%-18.43B | -48.51%-7.69B | -3.44%-11.29B | 3.28%-5.18B | 25.07%-10.92B | |
Gross profit | -121.47%-2.51B | -106.30%-552.65M | -33.17%11.69B | 23.92%8.78B | 213.88%17.5B | 95.46%7.08B | 48.53%5.57B | 100.88%3.62B | -19.79%3.75B | |
Selling expenses | -15.45%-289.67M | -7.75%-132.04M | ---- | -75.56%-250.91M | -95.40%-122.55M | -45.75%-142.92M | -31.46%-62.72M | -4.38%-98.06M | -16.52%-47.71M | 25.64%-93.94M |
Administrative expenses | 18.45%-1.85B | 40.03%-682.76M | ---- | -33.27%-2.27B | -54.38%-1.14B | -25.07%-1.71B | 3.84%-737.47M | 24.80%-1.36B | -0.60%-766.92M | 11.56%-1.81B |
Research and development expenses | 41.13%-1.1B | ---- | ---- | ---1.87B | ---- | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | -822.37%-989.43M | -20,168.85%-196.47M | ---- | -41.93%136.97M | 100.63%979K | 184.69%235.86M | -622.61%-156.61M | 57.10%-278.5M | 113.51%29.97M | -40.28%-649.15M |
-Other impairment is provision | -822.37%-989.43M | -20,168.85%-196.47M | ---- | -41.93%136.97M | 100.63%979K | 184.69%235.86M | -622.61%-156.61M | 57.10%-278.5M | 113.51%29.97M | -40.28%-649.15M |
Operating interest expense | ---- | ---- | ---- | ---- | ---- | 26.24%-239.51M | 91.97%-92.56M | 89.71%-324.73M | 31.78%-1.15B | 20.06%-3.16B |
Special items of operating profit | 183.58%2.43B | 72.43%-254.05M | ---- | -112.06%-2.9B | -1,008.45%-921.57M | -584.44%-1.37B | -1,172.08%-83.14M | 95.42%-199.98M | 100.77%7.76M | -332.77%-4.37B |
Operating profit | -195.39%-4.32B | -127.56%-1.82B | -68.27%4.53B | 10.85%6.6B | 331.44%14.27B | 251.35%5.95B | 152.28%3.31B | 188.14%1.69B | -19,695.33%-6.33B | |
Financing cost | -48.00%-618.38M | -41.61%-304.85M | ---- | ---417.84M | ---215.28M | ---- | ---- | ---- | ---- | ---- |
Share of profits of associates | -730.69%-1.28B | -108.98%-93.16M | ---- | -95.06%203.19M | -50.75%1.04B | 61.30%4.12B | 125.52%2.11B | 839.81%2.55B | 669.54%933.66M | -32.28%271.56M |
Share of profit from joint venture company | 320.00%27.11M | 22.96%2.68M | ---- | 85.98%-12.32M | -27.65%2.18M | -12.62%-87.88M | 110.78%3.02M | 24.65%-78.03M | 57.48%-27.97M | -101.60%-103.55M |
Earning before tax | -243.96%-6.19B | -129.83%-2.21B | -76.50%4.3B | -7.93%7.42B | 216.51%18.3B | 210.05%8.06B | 193.86%5.78B | 239.30%2.6B | -2,039.28%-6.16B | |
Tax | 155.91%545M | 116.33%191.89M | ---- | 48.15%-974.81M | -22.34%-1.18B | -245.60%-1.88B | -1,209.31%-960.56M | -392.32%-543.99M | -24.85%-73.36M | 46.58%-110.5M |
After-tax profit from continuing operations | -269.76%-5.65B | -132.37%-2.02B | -79.74%3.33B | -12.03%6.25B | 213.49%16.42B | 181.03%7.1B | 183.53%5.24B | 231.24%2.53B | -5,758.19%-6.27B | |
After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | ---- | -75.34%-942.63M | ---410.4M | ---537.61M | ---- | ---- |
Earning after tax | -269.76%-5.65B | -132.37%-2.02B | -78.51%3.33B | -6.63%6.25B | 229.29%15.48B | 164.78%6.69B | 174.96%4.7B | 231.24%2.53B | -5,758.19%-6.27B | |
Minority shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | 1,227.25%28.91M | --36.84M | ---2.57M | ---- | ---- |
Minority shareholders should account for non-continuing business profits | ---- | ---- | ---- | ---- | ---- | -52.29%-579.27M | ---256.97M | ---380.38M | ---- | ---- |
Minority profit | -209.86%-897.56M | -174.54%-541.81M | ---- | 248.45%817.03M | 430.20%726.86M | -43.72%-550.36M | -284.48%-220.13M | 36.53%-382.95M | 67.65%119.32M | -295.88%-603.39M |
Shareholders should account for profits from continuing business | ---- | ---- | ---- | ---- | ---- | 212.79%16.39B | --7.06B | --5.24B | ---- | ---- |
Shareholders should account for profits from non-continuing business | ---- | ---- | ---- | ---- | ---- | -131.10%-363.36M | ---153.43M | ---157.23M | ---- | ---- |
Profit attributable to shareholders | -289.25%-4.75B | -126.81%-1.48B | -84.34%2.51B | -20.12%5.52B | 215.31%16.03B | 187.05%6.91B | 189.70%5.08B | 220.58%2.41B | -2,774.07%-5.67B | |
Basic earnings per share | -289.76%-0.1797 | -126.94%-0.056 | -84.21%0.0947 | -19.42%0.2079 | 190.04%0.5998 | 160.61%0.258 | 173.70%0.2068 | 197.06%0.099 | -2,572.38%-0.2806 | |
Diluted earnings per share | -289.96%-0.1797 | -126.99%-0.056 | -84.20%0.0946 | -19.39%0.2075 | 189.88%0.5986 | 160.26%0.2574 | 173.59%0.2065 | 196.96%0.0989 | -2,572.38%-0.2806 | |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- |
Auditor | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofu Haohua (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.